LEADER 03649nam 2200589 450 001 000017104 005 20060131131141.0 010 $a0-12-181970-1$bVol. 70 P. A 010 $a0-12-181973-6$bVol. 73 P. B 010 $a0-12-181974-4$bVol. 74 P. C 010 $a0-12-181992-2$bVol. 92 P. E 010 $a0-12-181993-0$bVol. 93 P. F 010 $a0-12-182063-7$bVol. 162 P. L 010 $a0-12-182064-5$bVol. 163 P. M 100 $a20031211d--------km-y0itay0103----ba 101 0 $aeng 102 $aUS 200 1 $aImmunochemical techniques 210 $aNew York ; San Diego; Orlando...[etc.]$cAcademic Press 215 $av.$cill.$d24 cm 225 2 $aMethods in enzymology$v70, 73, 74, 92, 93, 162, 163 327 0 $aParte A / edited by Helen Van Vunakis, John J. Langone. - 1980. - XIX, 525 p.$aParte B / edited by John J. Langone, Helen Van Vunakis. - 1981. - XXII, 739 p.$aParte C / edited by John J. Langone, Helen Van Vunakis. - 1981. - XXIV, 729 p.$aParte E: Monoclonal antibodies and general immunoassay methods / edited by John J. Langone, Helen Van Vunakis. - c1983. - XXIV, 647 p.$aParte F: Conventional antiboides, Fc receptors, and cytotoxicity / edited by John J. Langone, Helen Van Vunakis. - 1983. - XX, 448 p.$aParte L: Chemotaxis and inflammation / edited by Giovanni Di Sabato. - c1988. - XXXIII, 717 p.$aParte M: Chemotaxis and inflammation / edited by Giovanni Di Sabato. - c1988. - XXIX, 819 p. 410 1$12001$aMethods in enzymology$v70, 73, 74, 92, 93, 162, 163 559 1 $aMonoclonal antibodies and general immunoassay methods 559 1 $aConventional antiboides, Fc receptors, and cytotoxicity 559 1 $aChemotaxis and inflammation 606 1 $aChimica$xImmunologia 676 $a571.964$v(21. ed.)$9Immunochimica e risposta immunitaria 702 1$aVan Vunakis,$bHelen 702 1$aLangone,$bJohn J. 702 1$aDi Sabato,$bGiovanni 801 0$aIT$bUniversità della Basilicata - B.I.A.$gRICA$2unimarc 912 $a000017104 996 $aImmunochemical techniques$984880 997 $aUNIBAS BAS $aAGRARIA CAT $aSTD031$b01$c20031211$lBAS01$h1634 CAT $c20050601$lBAS01$h1756 CAT $abatch$b01$c20050718$lBAS01$h1053 CAT $c20050718$lBAS01$h1112 CAT $c20050718$lBAS01$h1142 CAT $c20050718$lBAS01$h1156 CAT $aTTM$b30$c20060131$lBAS01$h1310 CAT $aTTM$b30$c20060131$lBAS01$h1311 FMT Z30 -1$lBAS01$LBAS01$mBOOK$1BASA2$APolo Tecnico-Scientifico$2DID$BDidattica$3PTS$630645$5A30645$820031211$eXIX, 525$f98$FConsultazione$hParte A Z30 -1$lBAS01$LBAS01$mBOOK$1BASA2$APolo Tecnico-Scientifico$2DID$BDidattica$630648$5A30648$820060131$eXXII, 739$f98$FConsultazione$hParte B Z30 -1$lBAS01$LBAS01$mBOOK$1BASA2$APolo Tecnico-Scientifico$2DID$BDidattica$630649$5A30649$820060131$eXXIV, 729$f98$FConsultazione$hParte C Z30 -1$lBAS01$LBAS01$mBOOK$1BASA2$APolo Tecnico-Scientifico$2DID$BDidattica$630664$5A30664$820060131$eXXIV, 647$f98$FConsultazione$hParte E: Monoclonal antibodies and general immunoassay methods Z30 -1$lBAS01$LBAS01$mBOOK$1BASA2$APolo Tecnico-Scientifico$2DID$BDidattica$630665$5A30665$820060131$eXX, 448$f98$FConsultazione$hParte F: Conventional antibodies, Fc receptors, and cytotoxicity Z30 -1$lBAS01$LBAS01$mBOOK$1BASA2$APolo Tecnico-Scientifico$2DID$BDidattica$673624$5A73624$820060131$eXXXIII, 717$f98$FConsultazione$hParte L: Chemotaxis and inflammation Z30 -1$lBAS01$LBAS01$mBOOK$1BASA2$APolo Tecnico-Scientifico$2DID$BDidattica$673625$5A73625$820060131$eXXIX, 819$f98$FConsultazione$hParte M: Chemotaxis and inflammation LEADER 03021nam 2200601Ia 450 001 9910455725803321 005 20200520144314.0 010 $a1-280-47211-1 010 $a9786610472116 010 $a0-19-802947-0 010 $a0-585-36123-1 035 $a(CKB)111004366530228 035 $a(StDuBDS)AH24085320 035 $a(SSID)ssj0000155253 035 $a(PQKBManifestationID)11158278 035 $a(PQKBTitleCode)TC0000155253 035 $a(PQKBWorkID)10121339 035 $a(PQKB)11023901 035 $a(MiAaPQ)EBC3052095 035 $a(Au-PeEL)EBL3052095 035 $a(CaPaEBR)ebr10142478 035 $a(CaONFJC)MIL47211 035 $a(OCoLC)922952681 035 $a(EXLCZ)99111004366530228 100 $a19980623d1999 uy 0 101 0 $aeng 135 $aur||||||||||| 181 $ctxt 182 $cc 183 $acr 200 10$aFinite and infinite goods$b[electronic resource] $ea framework for ethics /$fRobert Merrihew Adams 210 $aNew York $cOxford University Press$d1999 215 $a1 online resource (xiv, 410 p.) 300 $aBibliographic Level Mode of Issuance: Monograph 311 $a0-19-512848-6 320 $aIncludes bibliographical references (p. 391-400) and index. 327 $aGod as the good -- The transcendence of the good -- Well-being and excellence -- The sacred and the bad -- Eros -- Grace -- Devotion -- Idolatry -- Symbolic value -- Obligation -- Divine commands -- Abraham's dilemma -- Vocation -- Politics and the good -- Revelation of the good -- Moral faith. 330 $aRobert Adams gives a comprehensive philosophical account of a theistically-based framework for ethics. He draws on over 20 years of his published work to create this overarching framework, which is based upon the idea of a transcendent, infinite good, which is God, and its relation to the many finite examples of good in our experience. 330 $bRenowned scholar Robert Adams explores the relation between religion and ethics through a comprehensive philosophical account of a theistically-based framework for ethics. Adams' framework begins with the good rather than the right, and with excellence rather than usefulness. He argues that loving the excellent, of which adoring God is a clear example, is the most fundamental aspect of a life well lived. Developing his original and detailed theory, Adams contends that devotion, the sacred, grace, martyrdom, worship, vocation, faith, and other concepts drawn from religious ethics have been sorely overlooked in moral philosophy and can enrich the texture of ethical thought. 606 $aReligion and ethics 606 $aEthics 608 $aElectronic books. 615 0$aReligion and ethics. 615 0$aEthics. 676 $a291.5 700 $aAdams$b Robert Merrihew$0166641 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910455725803321 996 $aFinite and infinite goods$92248334 997 $aUNINA